Showing 15 posts of 90 posts found.

ImmTAC deal for Immunocore

June 27, 2013
Research and Development, Sales and Marketing Genentech, ImmTAC, oxford biotech

Oxford-based biotech company Immunocore has signed what could be a $300 million deal with Genentech to discover and bring to …

Roche cuts 1,000 R&D jobs

June 27, 2012
Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …

Genentech taken to task over Avastin production

May 15, 2012
Manufacturing and Production Genentech, Phil Taylor, avastin, manufacturing

FDA inspections of a manufacturing facility for Roche/Genentech’s cancer drug Avastin (bevacizumab) uncovered a number of deficiencies which could increase …

Gilead buys manufacturing plant from Genentech

August 9, 2011
Manufacturing and Production Genentech, Gilead, biologics

Roche unit Genentech has agreed to sell a clinical manufacturing plant in California to Gilead Sciences. The 70,000 sq. ft. …

Roche’s MabThera successor shows phase II promise

December 6, 2010
Research and Development, Sales and Marketing GA101, Genentech, GlycArt, MabThera, Roche, blood cancer, chronic lymphocytic leukaemia

The cancer drug Roche is developing as a second-generation successor to its blockbuster MabThera has shown promising results in a …

Pharma manufacturing news in brief

November 9, 2010
Manufacturing and Production Genentech, Hovione, Jacobs Engineering, Laureate Pharma, Recipharm, contract manufacturing, pharma manufacturing

Hovione wins a patent dispute, Genentech is awarded for a manufacturing plant and there are new contracts for Recipharm, Jacobs …

Novartis’ Lucentis recommended for wider EU licence

October 25, 2010
Sales and Marketing CHMP, Genentech, Lucentis, Novartis, diabetic macular edema, ranibizumab

Novartis’ Lucentis has been recommended for approval in Europe to treat people suffering from vison loss due to diabetes. The …

Genentech opens $400m fill-and-finish plant

April 8, 2010
Manufacturing and Production Genentech

US biotech giant Genentech has officially opened its new 296,000 sq. ft. biologics manufacturing facility in Hillsboro, near Portland, Oregon. …

Roche building

Genentech integration hits Roche profits

February 3, 2010
Sales and Marketing 2009 financials, Genentech, Roche

Roche achieved healthy sales growth in 2009 but saw a 22% drop in net income due to the cost gaining …

Awards recognise top pharma manufacturing projects

January 19, 2010
Manufacturing and Production Biogen, Genentech, Mannkind, Pfizer

The winners of the 2010 Facility of the Year Awards have been made public, with Pfizer grabbing two out of …

Roche lines up manufacturing and R&D reshuffle

April 1, 2009
Sales and Marketing Genentech, Roche

Genentech's decision to succumb to Roche's $48.8 billion merger bid has signalled a revamp of manufacturing, R&D and other divisions …

Genentech urges shareholders to reject Roche bid

February 24, 2009
Sales and Marketing Genentech, Roche

The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …

Biotech in 2008

December 31, 2008
Research and Development Genentech, InClone, biotech, economy, investment

The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …

Latest news from Datamonitor

July 28, 2008
Sales and Marketing Genentech, Roche

Roche looks to maximise Genentech potentialRoche has initiated efforts to acquire all outstanding shares in Genentech for approximately $43.7 billion, …

Genentech to buy biotech Tanox for $900 million

November 10, 2006
Sales and Marketing Genentech

 Genentech is to pay $919 million for Tanox, a biotech company which specialises in monoclonal antibodies.Genentech has been working with …

Latest content